Cargando…

Field-Deployable Treatments For Leishmaniasis: Intrinsic Challenges, Recent Developments and Next Steps

Leishmaniasis is a neglected tropical disease endemic primarily to low- and middle-income countries, for which there has been inadequate development of affordable, safe, and efficacious therapies. Clinical manifestations of leishmaniasis range from self-healing skin lesions to lethal visceral infect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pacheco-Fernandez, Thalia, Markle, Hannah, Verma, Chaitenya, Huston, Ryan, Gannavaram, Sreenivas, Nakhasi, Hira L, Satoskar, Abhay R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364832/ https://www.ncbi.nlm.nih.gov/pubmed/37492219 http://dx.doi.org/10.2147/RRTM.S392606

Ejemplares similares

Determinants of Innate Immunity in Visceral Leishmaniasis and Their Implication in Vaccine Development
por: Volpedo, Greta, et al.
Publicado: (2021)

Leishmania mexicana centrin knockout parasites promote M1-polarizing metabolic changes
por: Volpedo, Greta, et al.
Publicado: (2023)

Centrin-deficient Leishmania mexicana confers protection against New World cutaneous leishmaniasis
por: Volpedo, Greta, et al.
Publicado: (2022)

Revival of Leishmanization and Leishmanin
por: Pacheco-Fernandez, Thalia, et al.
Publicado: (2021)

The History of Live Attenuated Centrin Gene-Deleted Leishmania Vaccine Candidates
por: Volpedo, Greta, et al.
Publicado: (2022)

Leishmania major centrin knock-out parasites reprogram tryptophan metabolism to induce a pro-inflammatory response
por: Oljuskin, Timur, et al.
Publicado: (2023)

Biomarkers of Safety and Immune Protection for Genetically Modified Live Attenuated Leishmania Vaccines Against Visceral Leishmaniasis – Discovery and Implications
por: Gannavaram, Sreenivas, et al.
Publicado: (2014)

Immunity to Visceral Leishmaniasis Using Genetically Defined Live-Attenuated Parasites
por: Selvapandiyan, Angamuthu, et al.
Publicado: (2012)

Centrin-deficient Leishmania mexicana confers protection against Old World visceral leishmaniasis
por: Karmakar, Subir, et al.
Publicado: (2022)

Leishmania Major Centrin Gene-Deleted Parasites Generate Skin Resident Memory T-Cell Immune Response Analogous to Leishmanization
por: Ismail, Nevien, et al.
Publicado: (2022)

Mechanisms of Immunopathogenesis in Cutaneous Leishmaniasis And Post Kala-azar Dermal Leishmaniasis (PKDL)
por: Volpedo, Greta, et al.
Publicado: (2021)

Immunization with Live Attenuated Leishmania donovani Centrin(−/−) Parasites Is Efficacious in Asymptomatic Infection
por: Ismail, Nevien, et al.
Publicado: (2017)

Gene deleted live attenuated Leishmania vaccine candidates against visceral leishmaniasis elicit pro-inflammatory cytokines response in human PBMCs
por: Avishek, Kumar, et al.
Publicado: (2016)

Mitochondrial Associated Ubiquitin Fold Modifier-1 Mediated Protein Conjugation in Leishmania donovani
por: Gannavaram, Sreenivas, et al.
Publicado: (2011)

Deletion of Ubiquitin Fold Modifier Protein Ufm1 Processing Peptidase Ufsp in L. donovani Abolishes Ufm1 Processing and Alters Pathogenesis
por: Gannavaram, Sreenivas, et al.
Publicado: (2014)

Preclinical validation of a live attenuated dermotropic Leishmania vaccine against vector transmitted fatal visceral leishmaniasis
por: Karmakar, Subir, et al.
Publicado: (2021)

Modulation of Innate Immune Mechanisms to Enhance Leishmania Vaccine-Induced Immunity: Role of Coinhibitory Molecules
por: Gannavaram, Sreenivas, et al.
Publicado: (2016)

miR-21 Expression Determines the Early Vaccine Immunity Induced by LdCen(−/−) Immunization
por: Gannavaram, Sreenivas, et al.
Publicado: (2019)

Identification and Characterization of Genes Involved in Leishmania Pathogenesis: The Potential for Drug Target Selection
por: Duncan, Robert, et al.
Publicado: (2011)

Centrin-Deleted Leishmania donovani Parasites Help CD4(+) T Cells to Acquire Th1 Phenotype and Multi-Functionality Through Downregulation of CD200–CD200R Immune Inhibitory Axis
por: Singh, Rakesh K., et al.
Publicado: (2018)

Whole genome sequencing of live attenuated Leishmania donovani parasites reveals novel biomarkers of attenuation and enables product characterization
por: Gannavaram, Sreenivas, et al.
Publicado: (2017)

Cytokines and Their STATs in Cutaneous and Visceral Leishmaniasis
por: Cummings, Hannah E., et al.
Publicado: (2010)

Production of leishmanin skin test antigen from Leishmania donovani for future reintroduction in the field
por: Dey, Ranadhir, et al.
Publicado: (2023)

Live Attenuated Leishmania donovani Centrin Knock Out Parasites Generate Non-inferior Protective Immune Response in Aged Mice against Visceral Leishmaniasis
por: Bhattacharya, Parna, et al.
Publicado: (2016)

Role of Co-stimulation in Leishmaniasis
por: Tuladhar, Rashmi, et al.
Publicado: (2011)

Toll-like Receptor-9 (TLR-9) Signaling Is Crucial for Inducing Protective Immunity following Immunization with Genetically Modified Live Attenuated Leishmania Parasites
por: Bhattacharya, Parna, et al.
Publicado: (2023)

Innovations for the elimination and control of visceral leishmaniasis
por: Selvapandiyan, Angamuthu, et al.
Publicado: (2019)

Intradermal Immunization of Leishmania donovani Centrin Knock-Out Parasites in Combination with Salivary Protein LJM19 from Sand Fly Vector Induces a Durable Protective Immune Response in Hamsters
por: Fiuza, Jacqueline Araújo, et al.
Publicado: (2016)

Deletion of MIF gene from live attenuated LdCen(−/−) parasites enhances protective CD4(+) T cell immunity
por: Fiuza, Jacqueline Araújo, et al.
Publicado: (2023)

Ly6C(hi) inflammatory monocytes promote susceptibility to Leishmania donovani infection
por: Terrazas, Cesar, et al.
Publicado: (2017)

Lymphocytes influence Leishmania major pathogenesis in a strain-dependent manner
por: Musa, Md. Abu, et al.
Publicado: (2019)

Challenges for management of post kala-azar dermal leishmaniasis and future directions
por: Mondal, Dinesh, et al.
Publicado: (2014)

Next Steps for Ebola Vaccination: Deployment in Non-Epidemic, High-Risk Settings
por: Skrip, Laura A., et al.
Publicado: (2016)

A second generation leishmanization vaccine with a markerless attenuated Leishmania major strain using CRISPR gene editing
por: Zhang, Wen-Wei, et al.
Publicado: (2020)

Functional Optical Coherence Tomography for Intrinsic Signal Optoretinography: Recent Developments and Deployment Challenges
por: Kim, Tae-Hoon, et al.
Publicado: (2022)

Neutrophil-dendritic cell interaction plays an important role in live attenuated Leishmania vaccine induced immunity
por: Bhattacharya, Parna, et al.
Publicado: (2022)

Programmed cell death in Leishmania: biochemical evidence and role in parasite infectivity
por: Gannavaram, Sreenivas, et al.
Publicado: (2012)

Application of rapid in vitro co-culture system of macrophages and T-cell subsets to assess the immunogenicity of dogs vaccinated with live attenuated Leishmania donovani centrin deleted parasites (LdCen(−/−))
por: Viana, Kelvinson Fernandes, et al.
Publicado: (2016)

Differential Role of Leptin as an Immunomodulator in Controlling Visceral Leishmaniasis in Normal and Leptin-Deficient Mice
por: Maurya, Radheshyam, et al.
Publicado: (2016)

Enhanced attraction of sand fly vectors of Leishmania infantum to dogs infected with zoonotic visceral leishmaniasis
por: Chelbi, Ifhem, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_87f8b2n983jv6jss0i747hv2hg